Anti-Human IFN alpha Recombinant Antibody (TAB-074) (CAT#: TAB-074)
Recombinant monoclonal antibody to IFN alpha. It is a humanized monoclonal antibody. for treatment of systemic lupus erythematosus.
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
RNA Expression
Figure 1 RNA cell line category: Cell line enhanced (HeLa, hTERT-RPE1)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000197919-IFNA1
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000197919-IFNA1
Figure 1 RNA cell line category: Cell line enhanced (HeLa, hTERT-RPE1)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000197919-IFNA1
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000197919-IFNA1
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Mouse
- Derivation
- Humanized (from mouse)
- Type
- IgG1 - kappa
- Specificity
- Tested positive against native human antigen.
- Species Reactivity
- Human
- Applications
- WB
- MW
- 145.9 kDa
- Related Disease
- Systemic lupus erythematosus (SLE)
Product Property
- Purity
- >95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
- Storage
- Store it under sterile conditions at -20°C upon receiving. Recommend to pack the protein into smaller quantities for optimal storage.
Applications
- Application Notes
- The IFN alpha antibody has been reported in applications of Western Blot.
Target
- Alternative Names
- Rontalizumab;948570-30-7;rhuMAb IFN alpha;RG7415;IFNA1;interferon, alpha 1;interferon alpha-1/13;IFL;IFN;IFN ALPHA;IFN alpha 1b;IFN alphaD;IFNA13;IFNA@;interferon alpha 1b;leIF D;IFN-alpha 1b;IFN-alpha-1/13;interferon-alpha1;interferon alpha-D;IFN-ALPHA;I
- Gene ID
- 3439
- UniProt ID
- P01562
Related Resources
Please refer to Rontalizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Rontalizumab.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "IFNA1"
Select a product category from the dropdown menu below to view related products.
Please select product type
Mouse Antibody Products
Human Antibody Products
Neutralizing Antibody Products
Rabbit Monoclonal Antibody Products
IgG Antibody Products
ScFv Antibody Products
Fab Antibody Products
ADCC Enhanced Antibody Products
ScFv-Fc Chimera Products
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-747 | Anti-IFNA1 Recombinant Antibody (Faralimomab) | FuncS, IF, Neut, ELISA, FC, IP, IHC | IgG1 |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-074. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: WB, ELISA, IP, FC, FuncS, Neut, IF
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, ICC
Application: WB, IHC, FC, Cyt, ELISA
Application: ELISA, FC, IF, WB
Application: ELISA, PD, Activ, PK, Stim
Application: ELISA, FC, Inhib, IHC-Fr, WB, IP
Application: Inhib, FC, WB
Application: EM, ELISA, ICC, IHC-Fr, IHC-P, WB
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
